U.K. Adds to Arsenal With Approval of One-Shot J&J Vaccine
- Vaccine is the fourth to be cleared for use by U.K. regulators
- Shot was 66% effective against severe Covid-19 in trials
One-shot doses of the Johnson & Johnson Covid-19 vaccine.
Photographer: Mario Tama/Getty ImagesThis article is for subscribers only.
The U.K. cleared a Covid-19 vaccine for use from Johnson & Johnson, the first single-dose shot to be authorized in Britain against the disease.
J&J’s vaccine was given the green light for people ages 18 and over, the country’s drug regulator said Friday in a statement. The authorization from the Medicines and Healthcare Products Regulatory Agency gives Britain a fourth shot in its arsenal, though its use may be initially limited given more than half the population has already received one vaccine dose.